<DOC>
	<DOCNO>NCT01230463</DOCNO>
	<brief_summary>The primary aim study show non-inferiority 15 mg intraoperative dose ketorolac compare standard 30 mg ketorolac look VAS score 4 hour adult spine surgery .</brief_summary>
	<brief_title>Study Whether 15 mg Dose Ketorolac IV Effective 30 mg Dose .</brief_title>
	<detailed_description>Opioids traditionally cornerstone acute postoperative pain management . Problematic side effect nausea , vomit , ileus , urinary retention , excess sedation , respiratory depression significant disadvantage use opioids . Alternative treatment seek . The concept add nonsedating non opioid analgesic agent appeal validate previous study . Nonsteroidal anti-inflammatory drug ( NSAID ) nonsedating combine analgesic anti-inflammatory property ideal pain surgery . Ketorolac potent intravenous nonsteroidal anti-inflammatory drug ( NSAID ) , non selective cyclooxygenase inhibitor mediate pain , inflammation fever . It evaluate used treatment moderate severe pain include postoperative pain . Although intravenous route approve Health Canada , use support medical literature clinical practice . Previous study demonstrate effectiveness standard 30 mg intravenous ketorolac adjunct opioids postoperative pain relief . Standard parenteral dose recommend manufacturer healthy non elderly population 30 mg base number clinical trial . Alberta Health Services ( AHS ) Pharmacy formulary approve intravenous use ketorolac dosage range 10-30 mg depend patient 's weight medical comorbidities . NSAIDs , include ketorolac , analgesic ceiling effect high dos provide additional pain relief may increase likelihood side effect . Single dose IM ketorolac study past showing difference analgesia 30 90 mg dose . Because risk drug toxicity unwanted side effect , patient give low effective ketorolac dose . Low dose ketorolac study adolescent undergo spine surgery show dose 0.2mg/kg ( 11mg ) provide supplemental analgesia postoperatively . However , previous study find review literature use medline search look parallel comparison intraoperative dos ketorolac term efficacy safety profile .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Patients book 12 level spine laminectomy and/or decompression Adult 18 65 year Weight 50 110 kg Previous lumbar laminectomy Current anticoagulant use INR &gt; 1.2 Narcotic use &gt; 4 week Known allergy sensitivity NSAID morphine Renal insufficiency creatinine &gt; 100 umol/L Known liver disease History gastrointestinal bleeding Pregnancy , history bronchial asthma NSAID use 2 day surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Pain , Postoperative</keyword>
	<keyword>Ketorolac</keyword>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
	<keyword>Intraoperative Care</keyword>
</DOC>